Pharma giant Eli Lilly said it is negotiating to raise drug prices in Europe, starting in the U.K. with the weight-loss drug ...

Eli Lilly will raise the UK list price of its weight-loss and type 2 diabetes treatment Mounjaro by up to 170% to be in line ...

It comes as President Donald Trump pressures drugmakers to lower U.S. drug prices while hiking them abroad under a policy ...

Eli Lilly ( NYSE: LLY) will raise the cost of its GLP-1/GIP receptor agonist Mounjaro (tirzepatide), approved for type 2 ...

The new price, which also applies to Lilly's type 2 diabetes medicine that has the same name, is effective from September ...

Eli Lilly (LLY) recently collaborated with Superluminal Medicines to advance therapeutics targeting cardiometabolic diseases, ...

Eli Lilly is increasing Mounjaro's UK price by 170% to match European market levels, with the highest dose now costing £330.

Investing.com -- Eli Lilly (NYSE:LLY) has increased the price of its weight loss drug Mounjaro in the United Kingdom by up to ...

Pharma group seeks to address US complaints about ‘foreign freeloaders’ who rely on Americans to pay more for medicines ...

Eli Lilly is set to increase the UK price of its weight-loss and diabetes drug Mounjaro by 170%, aligning it with other ...

Trump administration demands lower prices in the U.S., forcing the pharmaceutical company to raise them in other markets ...